Related Experiment Video
Updated: Mar 19, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
A Multimodal Data Analysis Approach for Targeted Drug Discovery Involving Topological Data Analysis (TDA)
Muthuraman Alagappan1, Dadi Jiang1, Nicholas Denko2
1Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
This study introduces a novel multimodal in silico drug discovery technique. It integrates virtual high-throughput screening (vHTS), high-throughput screening (HTS), and fingerprint analysis with topological data analysis (TDA) for improved hit identification and lead generation.
Area of Science:
- Computational chemistry and pharmacology
- Drug discovery and development
Background:
- In silico drug discovery utilizes computational methods to identify drug compounds.
- Current techniques like virtual high-throughput screening (vHTS) and high-throughput screening (HTS) are often used in isolation.
- There is a need for integrated approaches to enhance hit identification and lead generation.
Purpose of the Study:
- To present a novel multimodal in silico technique for drug discovery.
- To integrate independent computational methods for more effective lead generation.
- To leverage topological data analysis (TDA) for enhanced compound selection.
Main Methods:
- Integration of virtual high-throughput screening (vHTS), high-throughput screening (HTS), and structural fingerprint analysis.
- Application of topological data analysis (TDA) to create a network from screening and analysis results.
- Identification of structurally diverse drug leads from compound libraries.
Main Results:
- The multimodal approach successfully transforms independent screening data into a TDA network.
- The technique facilitates the identification of diverse compound families.
- It maintains the advantages of established methods like vHTS and HTS.
Conclusions:
- The proposed multimodal in silico technique offers an advantageous approach for hit identification and lead generation.
- Integrating TDA with vHTS, HTS, and fingerprint analysis enables the selection of structurally diverse drug leads.
- This method enhances traditional drug discovery processes by combining multiple computational strategies.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Related Concept Videos
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...